BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10 related articles for article (PubMed ID: 38736108)

  • 1. DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer.
    Guo S; Miao M; Wu Y; Pan D; Wu Q; Kang Z; Zeng J; Zhong G; Liu C; Wang J
    Oncogene; 2024 May; 43(19):1399-1410. PubMed ID: 38480915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone.
    Fradet A; Bouchet M; Delliaux C; Gervais M; Kan C; Benetollo C; Pantano F; Vargas G; Bouazza L; Croset M; Bala Y; Leroy X; Rosol TJ; Rieusset J; Bellahcène A; Castronovo V; Aubin JE; Clézardin P; Duterque-Coquillaud M; Bonnelye E
    Oncotarget; 2016 Nov; 7(47):77071-77086. PubMed ID: 27776343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK12-inactivation-induced MYC signaling causes dependency on the splicing kinase SRPK1.
    Liang J; Gondane A; Itkonen HM
    Mol Oncol; 2024 May; ():. PubMed ID: 38775167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer.
    Yang H; Li Q; Chen X; Weng M; Huang Y; Chen Q; Liu X; Huang H; Feng Y; Zhou H; Zhang M; Pei W; Li X; Fu Q; Zhu L; Wang Y; Kong X; Lv K; Zhang Y; Sun Y; Ma M
    Nat Commun; 2024 May; 15(1):4296. PubMed ID: 38769295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress of anticancer drugs targeting CDK12.
    Yan Z; Du Y; Zhang H; Zheng Y; Lv H; Dong N; He F
    RSC Med Chem; 2023 Sep; 14(9):1629-1644. PubMed ID: 37731700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy.
    Zhang H; Xing C; Yan B; Lei H; Guan Y; Zhang S; Kang Y; Pang J
    Biomacromolecules; 2024 May; ():. PubMed ID: 38779908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.
    Zhang H; Zhou Y; Feng Y; Hou W; Chen Y; Xing Z; Zhang Y; Wei Q; Yin Y; Guo J; Hu H
    Clin Transl Med; 2024 May; 14(5):e1678. PubMed ID: 38736108
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.